Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office

Generated: November 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084422

« Back to Dashboard

NDA 084422 describes SECOBARBITAL SODIUM, which is a drug marketed by Anabolic, Barr, Everylife, Halsey, Ivax Pharms, Kv Pharm, Lannett, Parke Davis, Perrigo, Purepac Pharm, Valeant Pharm Intl, Vitarine, Watson Labs, West Ward, Whiteworth Town Plsn, Wyeth Ayerst, and Elkins Sinn, and is included in twenty NDAs. Additional details are available on the SECOBARBITAL SODIUM profile page.

The generic ingredient in SECOBARBITAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the secobarbital sodium profile page.
Summary for 084422
Ingredient:secobarbital sodium
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 084422

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Argus Health
Express Scripts
Johnson and Johnson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.